RTX 8-K
PositiveEarningsGuidance raisedImpairment / charge
Collins Aerospace leads segment profit growth; strong execution lifts FY2026 adjusted EPS outlook to $7.65–$7.75.
Filed 2026-10-20 06:57 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q3 2026 results and higher FY2026 outlook. RTX raised its outlook based on year-to-date performance and strong operational execution. New commercial and defense awards exceeded $81B, bringing backlog to a record $340B ($176B commercial; $164B defense).
Key Figures
| Metric | Q3 2026 | 9M 2026 |
|---|---|---|
| Sales | $25.0B, +11% Y/Y | $71.7B, +11% Y/Y |
| Operating profit | $3.34B, +32% Y/Y | $8.70B, +30% Y/Y |
| Net income attributable to common shareowners | $2.58B, +35% Y/Y | $6.78B, +33% Y/Y |
| GAAP diluted EPS | $1.89, +34% Y/Y | $4.96, +32% Y/Y |
| Adjusted net income attributable to common shareowners, non-GAAP | $3.09B, +34% Y/Y | $8.10B, +26% Y/Y |
| Adjusted diluted EPS, non-GAAP | $2.26, +33% Y/Y | $5.93, +25% Y/Y |
| Operating cash flow | $2.87B, −38% Y/Y | $8.27B, +29% Y/Y |
| Free cash flow, non-GAAP | $2.12B, −47% Y/Y | $6.31B, +33% Y/Y |
- Adjusted net income growth was driven by $1.1B of adjusted segment operating profit growth across all three segments, including $0.4B of IEEPA recovery; higher taxes and lower pension income partly offset the increase.
- Adjusted segment operating profit rose 50% at Collins Aerospace to $1.79B, 29% at Pratt & Whitney to $968M, and 32% at Raytheon to $1.13B. Pratt & Whitney’s reported operating profit included a $363M pre-tax customer bankruptcy charge.
- Q3 operating cash flow included ≈$0.3B of IEEPA recovery; capital expenditures were $749M. Cash and equivalents were $9.17B at 9/30/2026 vs $7.44B at 12/31/2025; debt carrying value was $37.4B vs $37.9B. Dividends paid were $984M vs $910M Y/Y.
Guidance
RTX cited year-to-date performance and operational execution in raising its full-year outlook.
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Adjusted sales, non-GAAP | FY2026 | $97B–$97.5B | $95B–$96B | Raised |
| Organic sales growth, non-GAAP | FY2026 | 10%–11% | 8%–9% | Raised |
| Adjusted EPS, non-GAAP | FY2026 | $7.65–$7.75 | $7.10–$7.25 | Raised |
| Free cash flow, non-GAAP | FY2026 | $9B–$9.2B | $8.5B–$8.75B | Raised |
Guidance changes, derived from earlier filings
| Metric | Period | Earlier guidance | Guidance now | Change |
|---|---|---|---|---|
| Adjusted sales, non-GAAP | FY2026 | $95.0B-$96.0B | $97B–$97.5B | raised |
| Organic sales growth, non-GAAP | FY2026 | 8%-9% | 10%–11% | raised |
| Adjusted EPS, non-GAAP | FY2026 | $7.10-$7.25 | $7.65–$7.75 | raised |
| Free cash flow, non-GAAP | FY2026 | $8.50B-$8.75B | $9B–$9.2B | raised |
Investor Takeaways
- Watch whether increased output and execution sustain the raised FY2026 outlook and translate the record backlog into sales.
The summary is written by an AI model reading the filing.
Model 005 · prompt v95 · 2026-10-20 14:35:24Z